Xellia Pharmaceuticals ApS

Xellia Pharmaceuticals ApS is a Manufacturer/Innovator company operating in the pharmaceutical industry.

Xellia Pharmaceuticals ApS is a specialty pharmaceutical company developing, manufacturing and commercializing anti-infective treatments against serious and often life-threatening bacterial and fungal infections. With over 115 years of experience, Xellia is a world-leading trusted supplier of several important established anti-infective drugs, comprising active pharmaceutical ingredients as well as injectable products.

Company type

Manufacturer/Innovator

Products and services

Custom Manufacturing, Finished Dosage Forms, APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services

Markets

Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)

Useful Links

Connect with Xellia Pharmaceuticals ApS on LinkedIn

Address

Xellia Pharmaceuticals ApS, Dalslandsgade 11, Copenhagen, Denmark, 2300